The Bronstein, Gewirtz & Grossman law firm has launched an investigation against Dentsply Sirona after the suspension of its Byte aligner sales. Three notes: 1. Dentsply Sirona voluntarily suspended ...

Needham analyst David Saxon maintained a Buy rating on DENTSPLY SIRONA (XRAY – Research Report) today and set a price target of $23.00.

DENTSPLY SIRONA Inc (Symbol: XRAY) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further ...

Oct 24 (Reuters) - (This Oct. 24 story has been corrected to say that Dentsply Sirona suspended sales of its 'Byte' teeth aligners, not all aligners in the headline) Dentsply Sirona (XRAY.O ...

Dentsply Sirona Inc. (NASDAQ:XRAY) shares are trading lower on Thursday. The company reported third-quarter adjusted earnings per share of 50 cents, beating the street view of 47 cents.